These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29632747)

  • 1. Bleeding in Locally Invasive Pelvic Malignancies: Is Hypofractionated Radiation Therapy a Safe and Effective Non-Invasive Option for Securing Hemostasis? A Single Institution Perspective.
    Shuja M; Nazli S; Mansha MA; Iqbal A; Mohamed R; Tunio MA; Alsaeed EF; Asiri M; Bayoumi Y
    Cureus; 2018 Feb; 10(2):e2137. PubMed ID: 29632747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-course accelerated radiotherapy in palliative treatment of advanced pelvic malignancies: a phase I study.
    Caravatta L; Padula GD; Macchia G; Ferrandina G; Bonomo P; Deodato F; Massaccesi M; Mignogna S; Tambaro R; Rossi M; Flocco M; Scapati A; Scambia G; Pacelli F; Valentini V; Cellini N; Morganti AG
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e627-31. PubMed ID: 22580117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palliative radiation therapy of symptomatic recurrent bladder cancer.
    Yi SK; Yoder M; Zaner K; Hirsch AE
    Pain Physician; 2007 Mar; 10(2):285-90. PubMed ID: 17387350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-course palliative radiotherapy for uterine cervical cancer.
    Kim DH; Lee JH; Ki YK; Nam JH; Kim WT; Jeon HS; Park D; Kim DW
    Radiat Oncol J; 2013 Dec; 31(4):216-21. PubMed ID: 24501709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and toxicity of conventionally fractionated pelvic radiation with a hypofractionated simultaneous versus conventionally fractionated sequential boost for patients with high-risk prostate cancer.
    McDonald AM; Jacob R; Dobelbower MC; Kim RY; Fiveash JB
    Acta Oncol; 2013 Aug; 52(6):1181-8. PubMed ID: 23544356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of palliative radiotherapy in bleeding control in patients with unresectable advanced gastric cancer.
    Yu J; Jung J; Park SR; Ryu MH; Park JH; Kim JH; Yoon SM
    BMC Cancer; 2021 Apr; 21(1):413. PubMed ID: 33858353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of efficacy and toxicity after high-dose pelvic reirradiation with palliative intent for genitourinary second malignant neoplasms or local recurrences after full-dose radiation therapy in the pelvis: A high-volume cancer center experience.
    Kamran SC; Harshman LC; Bhagwat MS; Muralidhar V; Nguyen PL; Martin NE; La Follette S; Faso S; Viswanathan AN; Efstathiou JA; Beard CJ
    Adv Radiat Oncol; 2017; 2(2):140-147. PubMed ID: 28740925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclical hypofractionated radiotherapy technique for palliative treatment of locally advanced head and neck cancer: institutional experience and review of palliative regimens.
    Finnegan TS; Bhatt NH; Shaughnessy JN; Perez C; Redman R; Silverman C; Bumpous J; Potts K; Dunlap NE
    J Community Support Oncol; 2016 Jan; 14(1):29-36. PubMed ID: 26870840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypofractionated Radiotherapy for Palliation in Locally Advanced Head and Neck Cancer.
    Spartacus RK; Dana R; Rastogi K; Bhatnagar AR; Daga D; Gupta K
    Indian J Palliat Care; 2017; 23(3):313-316. PubMed ID: 28827937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Image guided hypofractionated 3-dimensional radiation therapy in patients with inoperable advanced stage non-small cell lung cancer.
    Osti MF; Agolli L; Valeriani M; Falco T; Bracci S; De Sanctis V; Enrici RM
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e157-63. PubMed ID: 23182393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionated radiation leads to more rapid bleeding cessation in women with vaginal bleeding secondary to gynecologic malignancy.
    Moradi LA; Schneider CS; Deshane AS; Popple RA; Kim RY; Marcrom SR
    Radiat Oncol; 2022 Feb; 17(1):34. PubMed ID: 35164826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Phase II Toxicity End Point Trial (ICORG 99-09) of Accelerated Dose-escalated Hypofractionated Radiation in Non-small Cell Lung Cancer.
    Cagney DN; Thirion PG; Dunne MT; Fleming C; Fitzpatrick D; O'Shea CM; Finn MA; O'Sullivan S; Booth C; Collins CD; Buckney SJ; Shannon A; Armstrong JG
    Clin Oncol (R Coll Radiol); 2018 Jan; 30(1):30-38. PubMed ID: 29097074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.
    Movsas B; Hanlon AL; Lanciano R; Scher RM; Weiner LM; Sigurdson ER; Hoffman JP; Eisenberg BL; Cooper HS; Provins S; Coia LR
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):43-50. PubMed ID: 9747818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Retrospective Study of Rapid Symptom Response in Bleeding Gynecologic Malignancies With Short Course Palliative Radiation Therapy: Less is More.
    Butala AA; Lee DY; Patel RR; Latif NA; Haggerty AF; Paydar I; Jones JA; Taunk NK
    J Pain Symptom Manage; 2021 Feb; 61(2):377-383.e2. PubMed ID: 32822754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity assessment of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to prostate for intermediate- and high-risk prostate cancer.
    McCammon R; Rusthoven KE; Kavanagh B; Newell S; Newman F; Raben D
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):413-20. PubMed ID: 19362783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review.
    Matta R; Chapple CR; Fisch M; Heidenreich A; Herschorn S; Kodama RT; Koontz BF; Murphy DG; Nguyen PL; Nam RK
    Eur Urol; 2019 Mar; 75(3):464-476. PubMed ID: 30573316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective Analysis of Efficacy and Toxicity of Hypo-fractionated Radiotherapy in Breast Carcinoma.
    Mishra R; Khurana R; Mishra H; Rastogi M; Hadi R
    J Clin Diagn Res; 2016 Aug; 10(8):XC01-XC03. PubMed ID: 27656543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.